INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,519 | +19.7% | 4,575 | 0.0% | 0.10% | +31.5% |
| Q2 2023 | $96,533 | +23.8% | 4,575 | 0.0% | 0.07% | +19.7% |
| Q1 2023 | $78,004 | -14.7% | 4,575 | 0.0% | 0.06% | -11.6% |
| Q4 2022 | $91,409 | -7.7% | 4,575 | 0.0% | 0.07% | -18.8% |
| Q3 2022 | $99,000 | +10.0% | 4,575 | 0.0% | 0.08% | +18.1% |
| Q2 2022 | $90,000 | -16.7% | 4,575 | 0.0% | 0.07% | 0.0% |
| Q1 2022 | $108,000 | -13.6% | 4,575 | 0.0% | 0.07% | -8.9% |
| Q4 2021 | $125,000 | -10.7% | 4,575 | -10.1% | 0.08% | -23.3% |
| Q3 2021 | $140,000 | +2.2% | 5,089 | +1.4% | 0.10% | +2.0% |
| Q2 2021 | $137,000 | +522.7% | 5,019 | +675.7% | 0.10% | +461.1% |
| Q1 2021 | $22,000 | -26.7% | 647 | -28.6% | 0.02% | -30.8% |
| Q4 2020 | $30,000 | -76.9% | 906 | -77.5% | 0.03% | -77.8% |
| Q3 2020 | $130,000 | +622.2% | 4,035 | +503.1% | 0.12% | +485.0% |
| Q2 2020 | $18,000 | +200.0% | 669 | +67.2% | 0.02% | +185.7% |
| Q1 2020 | $6,000 | -33.3% | 400 | 0.0% | 0.01% | -30.0% |
| Q4 2019 | $9,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |